Carpenter Christopher R, Keim Samuel M, Upadhye Suneel, Nguyen H Bryant
Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.
J Emerg Med. 2009 Oct;37(3):319-27. doi: 10.1016/j.jemermed.2009.03.016. Epub 2009 May 8.
The prompt recognition and management of septic patients remains a challenge within the busy Emergency Department (ED). Prognostic screening aids have traditionally required time-delayed laboratory measurements not validated upon the emergency medicine population. Recently, a brief prognostic tool has been derived and subsequently validated in heterogeneous ED populations.
Can a risk-stratification tool predict 1-month mortality in ED patients with suspected infection?
Six studies evaluating the Mortality in the Emergency Department Sepsis (MEDS) score were identified and evaluated.
Higher MEDS scores are associated with increasing mortality. MEDS score's short- and long-term prognostic accuracy is superior to other sepsis scales as well as isolated biomarkers C-reactive protein and procalcitonin. MEDS' prognostic accuracy in severe sepsis is inferior to undifferentiated systemic inflammatory response syndrome (SIRS) patients.
The MEDS score is an accurate and reliable prognostic tool for 28-day mortality in ED SIRS patients, but may not be optimal for those with severe sepsis.
在繁忙的急诊科(ED)中,对脓毒症患者的及时识别和管理仍然是一项挑战。传统的预后筛查辅助手段需要延迟进行实验室检测,且这些检测在急诊医学人群中未得到验证。最近,一种简短的预后工具已被推导出来,并随后在异质性急诊科人群中得到验证。
风险分层工具能否预测疑似感染的急诊科患者的1个月死亡率?
确定并评估了六项评估急诊科脓毒症死亡率(MEDS)评分的研究。
MEDS评分越高,死亡率越高。MEDS评分的短期和长期预后准确性优于其他脓毒症量表以及单独的生物标志物C反应蛋白和降钙素原。MEDS在严重脓毒症中的预后准确性低于未分化的全身炎症反应综合征(SIRS)患者。
MEDS评分是急诊科SIRS患者28天死亡率的准确可靠的预后工具,但对于严重脓毒症患者可能并非最佳。